Home / EU Law

Legal News

EFPIA responds to article on transferable exclusivity voucher

Copyright © 2025 LexisNexis

Published on: 20 February 2023

Published by LNB News

LNB News 20/02/2023

Document Information

Issue Date: 20 February 2023

Published Date: 20 February 2023

Jurisdiction(s): European Union

Article summary

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a response to an article published in The Lancet criticising the pharmaceutical industry's role in the COVID-19 pandemic. EFPIA argues the article misrepresents the industry's efforts and contributions to combatting the pandemic, including the development of vaccines and treatments. The EFPIA also highlights the industry's partnerships with governments and other stakeholders to ensure access to essential medicines and vaccines. EFPIA concludes by emphasising the importance of collaboration and continued investment in research and development to address global health challenges.

Popular documents

Priority between loss reliefs in loss making companies

Priority between loss reliefs in loss making companiesWhy does it matter?A company that is a member of a group and has incurred any of the types of losses available for surrender by way of group relief may, without any further rules, have more than one way in which to use the loss. There are a

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of